Advertisement

Topics

Quantum Genomics SA ALQGC Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

10:42 EDT 10 Aug 2017 | BioPortfolio Reports

Summary

Quantum Genomics SA QGS is a biopharmaceutical company that develops therapies in the field of cardiovascular diseases. The company develops drugs to treat high blood pressure and heart failure. carries out research based on the brain aminopeptidase A inhibition, which is a triple action therapeutic platform. QGS's research programs include QGC001 for the treatment of high blood pressure with monotherapy drug; QGC011 for the treatment of hypertension through combination therapy; QGC006 for the optimization of the treatment of hypertension with a monotherapy drug; and QGC101 for the prevention and treatment of heart failure. The company partners with biotech research entities, academic teams, and pharmaceutical and bioscience companies to develop new drugs. QGS is headquartered in Paris, France.

Quantum Genomics SA Key Recent Developments

Jun 30,2017: Quantum Genomics appoints Professor Toshiro Fujita as member of its Scientific Advisory Board
May 23,2017: Quantum Genomics to Host Key Opinion Leader Event Focused on Phase IIa Hypertension Data and the Upcoming Clinical Trial in the United States
Mar 30,2017: Quantum Genomics: 2016 annual financial results
Oct 13,2016: Quantum Genomics announces 2016 firsthalf financial results and first nine months business update
Sep 06,2016: Quantum Genomics to Present at Rodman Renshaw 18th Annual Conference in New York on September 13

This comprehensive SWOT profile of Quantum Genomics SA provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Quantum Genomics SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*, x000D
x000D
Business description A detailed description of the company's operations and business divisions.x000D
Corporate strategy Analyst's summarization of the company's business strategy.x000D
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.x000D
Company history Progression of key events associated with the company.x000D
Major products and services A list of major products, services and brands of the company.x000D
Key competitors A list of key competitors to the company.x000D
Key employees A list of the key executives of the company.x000D
Executive biographies A brief summary of the executives' employment history.x000D
Key operational heads A list of personnel heading key departments/functions.x000D
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.x000D
Key manufacturing facilities A list of key manufacturing facilities of the company.x000D
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.x000D
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.x000D
x000D
Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,x000D
x000D
You get detailed information about the company and its operations to identify potential customers and suppliers.x000D
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.x000D
x000D
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.x000D
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. x000D
x000D
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.x000D
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.x000D
x000D
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.x000D
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.x000D
x000D
Gain key insights into the company for academic or business research.x000D
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Quantum Genomics SA ALQGC Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Quantum Genomics SA ALQGC Financial and Strategic SWOT Analysis Review [Report Updated: 07082017] Prices from USD $300"

Quick Search
Advertisement
 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...